CD44 and breast neoplasm: In bone marrow specimens of 50 patients with early breast tumors, CD44+/CD24low/- phenotype in cytokeratin-positive cells was detected in 72% of all disseminated tumor cells (DTC) compared with less than 10% in primary tumors [52].